Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medicinova (MNOV) Accumulated Expenses (2021 - 2025)

Medicinova (MNOV) has disclosed Accumulated Expenses for 8 consecutive years, with $2.6 million as the latest value for Q4 2025.

  • Quarterly Accumulated Expenses changed N/A to $2.6 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $2.6 million through Dec 2025, changed N/A year-over-year, with the annual reading at $2.6 million for FY2025, N/A changed from the prior year.
  • Accumulated Expenses for Q4 2025 was $2.6 million at Medicinova, up from $1.9 million in the prior quarter.
  • The five-year high for Accumulated Expenses was $3.8 million in Q3 2022, with the low at $636481.0 in Q4 2021.
  • Average Accumulated Expenses over 5 years is $1.9 million, with a median of $1.9 million recorded in 2021.
  • The sharpest move saw Accumulated Expenses skyrocketed 122.09% in 2022, then tumbled 51.18% in 2023.
  • Over 5 years, Accumulated Expenses stood at $636481.0 in 2021, then soared by 498.36% to $3.8 million in 2022, then crashed by 78.35% to $824390.0 in 2023, then soared by 104.6% to $1.7 million in 2024, then skyrocketed by 54.62% to $2.6 million in 2025.
  • According to Business Quant data, Accumulated Expenses over the past three periods came in at $2.6 million, $1.9 million, and $1.9 million for Q4 2025, Q3 2025, and Q2 2025 respectively.